Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124643412 | 12464341 | 2 | F | 2016 | 20160627 | 20160614 | 20160707 | EXP | CA-AEGERION PHARMACEUTICALS-AEGR002613 | AEGERION | 46.50 | YR | F | Y | 0.00000 | 20160707 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124643412 | 12464341 | 1 | PS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 5 MG, UNK | Y | L0409970 | 203858 | 5 | MG | CAPSULE | |||||
| 124643412 | 12464341 | 2 | SS | COUMADIN | WARFARIN SODIUM | 1 | VARIABLE DOSE | 0 | |||||||||||
| 124643412 | 12464341 | 3 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 124643412 | 12464341 | 4 | C | Ezetrol | EZETIMIBE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 124643412 | 12464341 | 5 | C | Asa | ASPIRIN | 1 | 81 MG, UNK | 0 | 81 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124643412 | 12464341 | 1 | Type IIa hyperlipidaemia |
| 124643412 | 12464341 | 2 | Product used for unknown indication |
| 124643412 | 12464341 | 3 | Product used for unknown indication |
| 124643412 | 12464341 | 4 | Product used for unknown indication |
| 124643412 | 12464341 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124643412 | 12464341 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124643412 | 12464341 | Epistaxis | |
| 124643412 | 12464341 | International normalised ratio increased | |
| 124643412 | 12464341 | Nasal disorder | |
| 124643412 | 12464341 | Therapy cessation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124643412 | 12464341 | 1 | 20160420 | 20160521 | 0 |